Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred stock
8.625% Series A Cumulative, Perpetual Preferred Stock
Preferred stock
8.375% Series B Cumulative, Perpetual Preferred Stock
Preferred stock
Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019       $ 73 $ 1,238,299 $ (1,194,384) $ 43,988
Balance (in shares) at Dec. 31, 2019     6,000 9,759,000      
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock related to 401(k) contribution         88   88
Issuance of common stock related to 401(k) contribution (in shares)       3,000      
Stock-based compensation expense         1,788   1,788
Disgorgement of stockholder's short-swing profits         13   13
Net loss           (4,758) (4,758)
Balance at Mar. 31, 2020       $ 73 1,240,188 (1,199,142) 41,119
Balance (in shares) at Mar. 31, 2020     6,000 9,762,000      
Balance at Dec. 31, 2019       $ 73 1,238,299 (1,194,384) 43,988
Balance (in shares) at Dec. 31, 2019     6,000 9,759,000      
Increase (Decrease) in Stockholders' Equity              
Net loss             (9,368)
Balance at Sep. 30, 2020       $ 83 1,241,711 (1,203,752) 38,042
Balance (in shares) at Sep. 30, 2020     5,000 11,022,000      
Balance at Mar. 31, 2020       $ 73 1,240,188 (1,199,142) 41,119
Balance (in shares) at Mar. 31, 2020     6,000 9,762,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options         10   10
Exercise of stock options (in shares)       2,000      
Issuance of common stock related to ESPP         26   26
Issuance of common stock related to ESPP (in shares)       1,000      
Stock-based compensation expense         773   773
Issuance of common stock related to Series Y preferred stock conversion       $ 10 (10)    
Issuance of common stock related to Series Y preferred stock conversion (in shares)     (1,000) 1,253,000      
Net loss           (3,533) (3,533)
Balance at Jun. 30, 2020       $ 83 1,240,987 (1,202,675) 38,395
Balance (in shares) at Jun. 30, 2020     5,000 11,018,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options         16   16
Exercise of stock options (in shares)       4,000      
Stock-based compensation expense         708   708
Net loss           (1,077) (1,077)
Balance at Sep. 30, 2020       $ 83 1,241,711 (1,203,752) 38,042
Balance (in shares) at Sep. 30, 2020     5,000 11,022,000      
Balance at Dec. 31, 2020 $ 49     $ 84 1,267,377 (1,181,086) 86,424
Balance (in shares) at Dec. 31, 2020 984,000   5,000 11,229,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options         388   388
Exercise of stock options (in shares)       24,000      
Exercise of common stock warrants (in shares)       5,000      
Issuance of common stock related to 401(k) contribution         90   90
Issuance of common stock related to 401(k) contribution (in shares)       2,000      
Stock-based compensation expense         2,898   2,898
Preferred stock dividends         (707)   (707)
Net loss           (7,373) (7,373)
Balance at Mar. 31, 2021 $ 49     $ 84 1,270,046 (1,188,459) 81,720
Balance (in shares) at Mar. 31, 2021 984,000   5,000 11,260,000      
Balance at Dec. 31, 2020 $ 49     $ 84 1,267,377 (1,181,086) $ 86,424
Balance (in shares) at Dec. 31, 2020 984,000   5,000 11,229,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options (in shares)             74,805
Net loss             $ (14,046)
Balance at Sep. 30, 2021 $ 49     $ 85 1,306,582 (1,195,132) 111,584
Balance (in shares) at Sep. 30, 2021 984,000 2,000 5,000 11,311,000      
Balance at Mar. 31, 2021 $ 49     $ 84 1,270,046 (1,188,459) 81,720
Balance (in shares) at Mar. 31, 2021 984,000   5,000 11,260,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options       $ 1 593   594
Exercise of stock options (in shares)       49,000      
Issuance of common stock related to ESPP         17   17
Issuance of common stock related to ESPP (in shares)       1,000      
Stock-based compensation expense         768   768
Issuance of stock         37,140   37,140
Issuance of stock, net (in shares)   2,000          
Preferred stock dividends         (1,424)   (1,424)
Net loss           (2,237) (2,237)
Balance at Jun. 30, 2021 $ 49     $ 85 1,307,140 (1,190,696) 116,578
Balance (in shares) at Jun. 30, 2021 984,000 2,000 5,000 11,310,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options         31   31
Exercise of stock options (in shares)       1,000      
Stock-based compensation expense         779   779
Preferred stock dividends         (1,368)   (1,368)
Net loss           (4,436) (4,436)
Balance at Sep. 30, 2021 $ 49     $ 85 $ 1,306,582 $ (1,195,132) $ 111,584
Balance (in shares) at Sep. 30, 2021 984,000 2,000 5,000 11,311,000